Syngene's flexible business model is built around providing customised services to meet the individual requirements of each client and to create long-term value for all stakeholders. We use our experience and expertise within a framework, which includes an environment of high quality, regulatory and safety compliance, integrity, delivering scientific solutions to clients and growing our business sustainably.
1.4 Mn sq. ft. of R&D and manufacturing facilities accredited with major regulatory compliances.
3,996 scientists with strong experience, expertise, knowledge and skills driving our R&D activities.
We have long-term relationships with 62 clients across industries i.e. almost 20% of our client base.
Investments in new areas such as bioinformatics, sophisticated Immuno Oncology (IO) assays and CAR-T design to add value to clients' projects.
Strong balance sheet and positive cash flows to support future growth.
Earlier, our client engagement began with a short-term contract for a single service, which later extended into long-term contracts for multiple services. Today, bolstered by the trust and reputation we have built as a strategic partner, clients are increasingly signing us for multiple services.
Addressing complex projects and delivering solutions to increase the success rate of R&D activities.
Best in industry quality standards adhered to in every phase of the drug-discovery continuum.
Customised and dedicated resources with flexibility for upward and downward regulation.
Robust systems to ensure data confidentiality and intellectual property (IP) protection.
Faster project execution and timely delivery while maintaining quality standards.